National Bank of Canada
SANA icon

National Bank of Canada’s Sana Biotechnology SANA Stock Holding History

National Bank of Canada’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-108
Closed -$29.5K – 3169
2025
Q2 		$29.5K Hold
108
– – ﹤0.01% 2080
2025
Q1 		$18.1K Buy
+108
New +$302 ﹤0.01% 2112

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Bank of Canada's SANA Position: Q3 2025 in Review

National Bank of Canada sold out of Sana Biotechnology (SANA) in Q3 2025, closing a stake of 10,800 shares — an estimated $29.5K sold.

National Bank of Canada first reported a position in SANA in Q4 2021 and held it in 14 quarters. The position peaked at $29.5K in Q2 2025. 178 funds tracked by Wall St. Rank hold SANA as of Q3 2025.

  • National Bank of Canada reported no remaining Sana Biotechnology position as of Q3 2025 after selling out during the quarter.
  • National Bank of Canada sold 10,800 Sana Biotechnology shares in Q3 2025, an estimated $29.5K.
  • National Bank of Canada first reported a position in Sana Biotechnology in Q4 2021 and held it in 14 quarters.
  • National Bank of Canada's Sana Biotechnology position peaked at $29.5K in Q2 2025.
  • 178 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.